| # | Drug | Count |
|---|---|---|
| 0 | OLANZAPINE | 11 |
| 1 | OLANZAPINE PAMOATE | 10 |
| 2 | PREDNISOLONE | 9 |
| 3 | PREDNISOLONE ORAL | 9 |
| 4 | PREDNISOLONE ORAL SOLUTION | 9 |
| 5 | PREDNISONE | 7 |
| 6 | LEVOTHYROXINE SODIUM | 5 |
| 7 | BRENTUXIMAB VEDOTIN | 4 |
| 8 | CALCIUM GLUCONATE | 4 |
| 9 | DEXAMETHASONE SODIUM PHOSPHATE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | REPOTRECTINIB | 1 | 0.0036 |
| 1 | TRICLOSAN | 1 | 0.0017 |
| 2 | TOPICAL ANESTHETIC | 1 | 0.0012 |
| 3 | ETOPOSIDE PHOSPHATE | 2 | 0.0012 |
| 4 | BENZOCAINE | 1 | 0.0010 |
| 5 | ONASEMNOGENE ABEPARVOVEC-XIOI | 2 | 0.0009 |
| 6 | IDARUBICIN HYDROCHLORIDE | 1 | 0.0009 |
| 7 | DEFLAZACORT | 2 | 0.0008 |
| 8 | IBANDRONATE SODIUM | 2 | 0.0006 |
| 9 | OMADACYCLINE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 19 |
| 1 | Atypical Antipsychotic [EPC] | 14 |
| 2 | Aromatase Inhibitor [EPC] | 8 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 |
| 4 | Kinase Inhibitor [EPC] | 7 |
| 5 | Angiotensin Converting Enzyme Inhibitor [EPC] | 6 |
| 6 | Benzodiazepine [EPC] | 6 |
| 7 | Alkylating Drug [EPC] | 5 |
| 8 | Mood Stabilizer [EPC] | 5 |
| 9 | Anti-epileptic Agent [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 4 | 0.0004 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 2 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 3 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 5 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 6 | Aromatase Inhibitor [EPC] | 8 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 9 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |